These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23999363)

  • 21. [Biochemical markers of bone turnover. New aspect. Changes in bone turnover markers during fracture healing].
    Ichimura S; Hasegawa M
    Clin Calcium; 2009 Aug; 19(8):1102-8. PubMed ID: 19638693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
    Tanaka Y
    Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical markers of bone remodeling.
    Kleerekoper M
    Am J Med Sci; 1996 Dec; 312(6):270-7. PubMed ID: 8969616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of bone formation and resorption: biological and clinical perspective.
    Rodan GA
    J Cell Biochem Suppl; 1998; 30-31():55-61. PubMed ID: 9893256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone and metabolism: a complex crosstalk.
    Lieben L; Callewaert F; Bouillon R
    Horm Res; 2009 Jan; 71 Suppl 1():134-8. PubMed ID: 19153524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
    Bonnet N; Pierroz DD; Ferrari SL
    J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone remodeling: A review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip.
    Fazzalari NL
    Semin Cell Dev Biol; 2008 Oct; 19(5):467-72. PubMed ID: 18771742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central control of bone remodeling by neuromedin U.
    Sato S; Hanada R; Kimura A; Abe T; Matsumoto T; Iwasaki M; Inose H; Ida T; Mieda M; Takeuchi Y; Fukumoto S; Fujita T; Kato S; Kangawa K; Kojima M; Shinomiya K; Takeda S
    Nat Med; 2007 Oct; 13(10):1234-40. PubMed ID: 17873881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum leptin is correlated to high turnover in osteoporosis.
    Hipmair G; Böhler N; Maschek W; Soriguer F; Rojo-Martínez G; Schimetta W; Pichler R
    Neuro Endocrinol Lett; 2010; 31(1):155-60. PubMed ID: 20150868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines and osteoporosis.
    Cohen-Solal M; de Vernejoul MC
    Rev Rhum Engl Ed; 1996 Feb; 63(2):83-6. PubMed ID: 8689292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone turnover markers in the management of postmenopausal osteoporosis.
    Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
    Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of bone loss in disuse osteoporosis.
    Alexandre C; Vico L
    Joint Bone Spine; 2011 Dec; 78(6):572-6. PubMed ID: 21664854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone remodeling: a role in bone homeostasis].
    Endo I; Matsumoto T
    Nihon Rinsho; 2009 May; 67(5):873-8. PubMed ID: 19432103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of innervation in the control of bone remodeling.
    Chenu C
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):132-4. PubMed ID: 15615111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.
    Siddiqui JA; Partridge NC
    Physiology (Bethesda); 2016 May; 31(3):233-45. PubMed ID: 27053737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How is bone remodeling regulated?].
    Takeuchi Y
    Nihon Rinsho; 2009 May; 67(5):897-902. PubMed ID: 19432106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying genes that regulate bone remodeling as potential therapeutic targets.
    Krane SM
    J Exp Med; 2005 Mar; 201(6):841-3. PubMed ID: 15781576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of postmenopausal bone loss and treatment of osteoporosis.
    Kleerekoper M
    Semin Reprod Med; 2005 May; 23(2):141-8. PubMed ID: 15852199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis: a neuroskeletal disease?
    Takeda S
    Int J Biochem Cell Biol; 2009 Mar; 41(3):455-9. PubMed ID: 18761104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". The mechanism of bone fragility].
    Saito M
    Clin Calcium; 2015 Sep; 25(9):1301-6. PubMed ID: 26320529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.